CEACAM5 and neoplasm: This study developed a series of anti-carcinoembryonic antigen (CEA) CH2 domain-deleted antibodies to evaluate their rapid, high-level tumor targeting combined with fast blood clearance for immunoPET imaging in two colorectal cancer mouse models.